Preliminary data presented at the AACR-NCI-EORTC conference will provide insights into the potential of ZW191 in patients with advanced solid ...
The Phase 1 results and Cyclin E1 biomarker findings accepted for presentation at AACR-NCI-EORTC reinforce our biomarker-driven strategy for azenosertib in Cyclin E1-positive platinum-resistant ...
Market Expansion Driven by Environmental Regulations, Consumer Consciousness, and Corporate Sustainability Initiatives Across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback